Lexaria Bioscience Debt to Equity Ratio Insights

Lexaria Bioscience Corp (LEXX)

2.25 0.00 (0.00%) USD | NASDAQ | Apr 19, 13:01

Debt to Equity Ratio Chart

Historical Debt to Equity Ratio Data

View and export this data back to 2007. Upgrade now.

Date	Value
February 29, 2024	0.00
November 30, 2023	0.00
August 31, 2023	0.00
May 31, 2023	0.00
February 28, 2023	0.00
November 30, 2022	0.00
August 31, 2022	0.00
May 31, 2022	0.0009
February 28, 2022	0.0007
November 30, 2021	0.0007
August 31, 2021	0.0006
May 31, 2021	0.0007
February 28, 2021	0.0006
November 30, 2020	0.0164
August 31, 2020	0.0121
May 31, 2020	0.009
February 29, 2020	0.00
November 30, 2019	0.00
August 31, 2019	0.00
May 31, 2019	0.00
February 28, 2019	0.00
November 30, 2018	0.00
August 31, 2018	0.00
May 31, 2018	0.00
February 28, 2018	0.00

Date	Value
November 30, 2017	0.00
August 31, 2017	0.00
May 31, 2017	0.0138
February 28, 2017	0.0651
November 30, 2016	0.0558
August 31, 2016	0.1691
May 31, 2016	0.3729
February 29, 2016	0.00
November 30, 2015	0.00
August 31, 2015	0.00
May 31, 2015	0.00
February 28, 2015	0.00
November 30, 2014	0.00
July 31, 2014	0.227
April 30, 2014	0.2437
January 31, 2014	0.6341
October 31, 2013	0.6085
July 31, 2013	0.5836
April 30, 2013	0.6121
January 31, 2013	0.639
October 31, 2012	0.6784
July 31, 2012	0.692
April 30, 2012	0.695
January 31, 2012	0.6083
October 31, 2011	0.5087

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

Minimum

May 2019

0.0164

Maximum

Nov 2020

0.0021

Average

Median